z-logo
open-access-imgOpen Access
Cost-effectiveness of laparoscopic versus open distal pancreatectomy for pancreatic cancer
Author(s) -
Kurinchi Selvan Gurusamy,
Deniece Riviere,
C. J. H. van Laarhoven,
Marc G. Besselink,
Mohammad Abu Hilal,
Brian R Davidson,
Steve Morris
Publication year - 2017
Publication title -
plos one
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.99
H-Index - 332
ISSN - 1932-6203
DOI - 10.1371/journal.pone.0189631
Subject(s) - medicine , pancreatectomy , pancreatic cancer , distal pancreatectomy , confidence interval , laparoscopy , quality adjusted life year , general surgery , cost effectiveness , surgery , pancreas , cancer , risk analysis (engineering)
Background A recent Cochrane review compared laparoscopic versus open distal pancreatectomy for people with for cancers of the body and tail of the pancreas and found that laparoscopic distal pancreatectomy may reduce the length of hospital stay. We compared the cost-effectiveness of laparoscopic distal pancreatectomy versus open distal pancreatectomy for pancreatic cancer. Method Model based cost-utility analysis estimating mean costs and quality-adjusted life years (QALYs) per patient from the perspective of the UK National Health Service. A decision tree model was constructed using probabilities, outcomes and cost data from published sources. A time horizon of 5 years was used. One-way and probabilistic sensitivity analyses were undertaken. Results The probabilistic sensitivity analysis showed that the incremental net monetary benefit was positive (£3,708.58 (95% confidence intervals (CI) -£9,473.62 to £16,115.69) but the 95% CI includes zero, indicating that there is significant uncertainty about the cost-effectiveness of laparoscopic distal pancreatectomy versus open distal pancreatectomy. The probability laparoscopic distal pancreatectomy was cost-effective compared to open distal pancreatectomy for pancreatic cancer was between 70% and 80% at the willingness-to-pay thresholds generally used in England (£20,000 to £30,000 per QALY gained). Results were sensitive to the survival proportions and the operating time. Conclusions There is considerable uncertainty about whether laparoscopic distal pancreatectomy is cost-effective compared to open distal pancreatectomy for pancreatic cancer in the NHS setting.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here